CDC Recommends Routine Use of Beyfortus for RSV Disease Prevention in Infants

The CDC has unanimously voted to recommend routine use of the anti-RSV monoclonal antibody Beyfortus to prevent RSV disease in infants.

Related Keywords

Mandy Cohen ,Centers For Disease ,Advisory Committee On Immunization Practices ,Disease Control ,Advisory Committee ,Immunization Practices ,Thomas Triomphe Executive Vice President ,Adolescent Immunization ,